AUSTIN, Texas, July 21, 2025 -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to implant an FDA-approved novel leadless system that provides cardiac resynchronization therapy to patients with heart failure. Cardiac resynchronization therapy improves the timing of the heart's contractions, helping to restore the normal rhythm of the heartbeat. The first procedure was recently performed by Robert Canby, M.D., cardiac electrophysiologist at TCAI. "This technology marks a significant advancem
오스틴, 텍사스, 2025년 7월 21일 -- 세인트 데이비드 메디컬 센터(St. David's Medical Center) 산하 텍사스 심장부정맥연구소(Texas Cardiac Arrhythmia Institute, TCAI)의 심장 전기생리학 전문의들이 심장 재동기화 치료를 제공하는 FDA 승인 신기술 무선 시스템을 미국 최초로 심부전 환자에게 이식하는 데 성공했다. 심장 재동기화 치료는 심장 수축 타이밍을 개선해 심장 박동을 정상 리듬으로 회복시키는 방법이다. 이번 첫 시술은 TCAI의 심장 전기생리학 전문의 로버트 캔비 박사(Robert Canby, M.D.)가 집도했다. TCAI의 심장 전기생리학자이자 의학총책임자인 안드레아 나탈레(Andrea Natale) 박사(F.H.R.S., F.A.C.C., F.E.S.C.)는 "이 기술은 이전까지 심장 재동기화 치료 선택지가 거의 없었던 환자들을 위한 치료 방식에 중대한 진전을 가져왔다"며, "텍사스 심장부정맥 연구소는 전 세계 환자들에게 가장 진보된 근거 기반 치료를 제공하는 데 전념하고 있으며, 캔비 박사의 리더십 덕분에 그 약속을 성공적으로 이행했다"라
BEIJING, July 18, 2025 -- This is a report from China.org.cn: At the 3rd China International Supply Chain Expo (CISCE), Canadian host Simon embarked on an immersive exploration of the advanced manufacturing zone—highlighting how global supply chains are accelerating the future of aviation, drones, and intelligent manufacturing. At the PwC booth, Simon encountered the VERTAXI eVTOL (electric vertical take-off and landing aircraft), a new-generation passenger drone designed for urban air mobility. Capable of autonomous flight and rooftop takeoff, the aircraft re
BEIJING, July 18, 2025 -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity. Fangzhou's founder, chairman, and CEO Dr. Xie F
SHANGHAI, July 18, 2025 -- Jointly organized by the China Chamber of Commerce for Import & Export of Medicines & Health Products and Sinoexpo Informa Markets, the "Healthplex Expo 2025, Natural & Nutraceutical Products China 2025" (HNC 2025) was successfully held from June 24 to 26 at the National Exhibition and Convention Center (Shanghai). The HNC 2025 once again achieved a historic breakthrough in scale, winning high praise from all participants. Held concurrently with Hi & Fi Asia-China, ProPak China & FoodPack China, and Starch Expo, the HNC built a business
XIAMEN, China, July 18, 2025 -- Brain-Computer Interface (BCI) technology is redefining human-machine interaction by establishing direct communication between the brain and external devices. This transformative innovation is driving profound societal impact across industries: revolutionizing neurological disease treatment (e.g., epilepsy, Parkinson's, and depression), enhancing educational outcomes through improved focus, and enabling seamless industrial human-robot collaboration. With aging populations and rising neurological disorders worldwide, BCI's healthcare applications are experiencin
GOTHENBURG, Sweden, July 18, 2025 -- "The positive start to 2025 continued in the second quarter, with stable organic growth in order intake and sales, and our margins strengthened despite strong headwinds from tariffs and negative currency effects," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased organically by 4.1% while order intake rose by 4.4% organically. Business area Acute Care Therapies continues to be successful in handling the increased demand for ventilators, and the order intake in ECLS consumables remains high. The
LONDON, July 18, 2025 -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual World Brain Day, with the theme "Brain Health for All Ages." The official event of World Brain Day is a webinar, open to the public, taking place at 1:00 p.m. BST. World Brain Day is an annual event uniting the global community to protect and promote healthy brains. The webinar serves as a global call to action for both individuals, healthcare providers, non-governmental organizations, community leaders, policy-makers, and institutions to share meaningf
[ 메디채널 김갑성 기자 ] New Funding Fuels Growth in Medical Insurance and Innovation in Preventive Healthcare HONG KONG, July 18, 2025 -- Bowtie, Hong Kong's first virtual insurer[1], is proud to announce securing up to US$70 million in its Series C funding round. Led by Sun Life Hong Kong Limited ("Sun Life"), this marks the largest funding round for digital health insurers in Asia with a direct-to-consumer model. Bowtie continues to lead in Hong Kong's digital insurance market, ranking first in the direct channel[2], and securing the 9th position across all dist
SEOUL, South Korea, July 18, 2025 -- DeepQure announced today that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company's novel laparoscopic renal denervation (RDN) system, for the treatment of atrial fibrillation (AF). The trial is designed to evaluate the safety and efficacy of laparoscopic RDN in patients with recurrent AF following pulmonary vein isolation (PVI) and resistant hypertension. It will be conducted as a multicenter, prospective, single-arm, open-label exploratory study. HyperQure™ is a next-gene